Augmedix, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Augmedix, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2019 to 2023.
  • Augmedix, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $59K, a 98.8% decline year-over-year.
  • Augmedix, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $43.4M.
  • Augmedix, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.24M, a 103% decline from 2021.
  • Augmedix, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $37.8M, a 43.2% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $43.4M +$44.6M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 -$1.24M -$39.1M -103% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $37.8M +$11.4M +43.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 $26.4M +$9.25M +53.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $17.2M Jan 1, 2019 Dec 31, 2019 10-K/A 2021-06-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.